PANAZEE
LIVE

Serial Number

97082024

Owner

Panazee GmbH

Attorney

Marcus P. Dolce

Filing Date

Oct 19, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PANAZEE Trademark

Serial Number: 97082024 • Registration: 7390173

PANAZEE is a trademark filed by Panazee GmbH on October 19, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Panazee GmbH

Bahnhofstr. 5
Simmelsdorf 91245 , DE

Entity Type: 99

Trademark Details

Filing Date

October 19, 2021

Registration Date

May 21, 2024

Published for Opposition

March 5, 2024

Goods & Services

Medical laboratory research instruments for scientific use, namely, for in vitro diagnostics; Downloadable mobile applications for displaying health information; Downloadable computer software for health monitoring in the field of healthcare; Downloadable artificial intelligence computer software for displaying health information in the field of healthcare; Laboratory apparatus and instruments, namely, point-of-care diagnostic machines for analyzing concentrations in body fluids for laboratory or research use; Laboratory apparatus and instruments, namely, point-of-care diagnostic for analyzing genome information

Reactants for medical diagnosis; Diagnostic preparations for medical or veterinary purposes; Reagents for use in diagnostic tests for medical purposes; Reagents and media for medical and veterinary diagnostic purposes; Medical diagnostic reagents and assays for testing of body fluids; Diagnostic preparations and materials for medical purposes; Diagnostic preparations for medical purposes; Diagnostic chemical reagents for medical use

Retail and wholesale store services, featuring medical diagnostic supplies

Diagnostic preparations for scientific or research use; Diagnostic preparations and materials for scientific or research use

Medical testing for diagnostic or treatment purposes; Medical analysis services for the diagnosis of cancer; Medical services for the diagnosis of conditions of the human body; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for cancer diagnosis and prognosis; Medical analysis for the diagnosis and treatment of persons; RNA and DNA screening and analysis for cancer diagnosis and prognosis; Medical testing services relating to the diagnosis and treatment of disease; Medical diagnostic services, namely, testing, monitoring and reporting; Health counseling; Health centre services; Public health counseling; Health clinic services; Advisory services relating to medical problems; Professional consultancy relating to health; Professional consultancy relating to health care; Health care consultancy services; Health advice and information services; Medical health assessment services; Provision of health information; Providing health care information via a global computer network; Rental of equipment for human healthcare, namely, medical equipment rental; Medical and health services relating to DNA, genetics and genetic testing; Medical analysis services relating to the treatment and monitoring of patients; Individual medical counseling services provided to patients; Providing information to patients in the field of administering medications; Medical analysis services relating to the treatment of patients; Medical analysis services provided by medical laboratories for the analysis of blood samples taken from patients; Medical analysis services provided by medical laboratories for the analysis of body fluid samples taken from patients; Medical care and analysis services relating to patient treatment; Medical assistance services in the nature of medical information provided from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Medical analysis services relating to the treatment of persons provided by a medical laboratory

Medical tools for medical diagnostics, namely, for in-vitro diagnostic of body fluids; Medical diagnostic, examination, and monitoring equipment for in-vitro diagnostic of body fluids; Electromedical diagnostic instruments, namely, for in-vitro diagnostic of body fluids; Spectrum analyzers for use in medical diagnosis for in-vitro diagnostic of body fluids; Testing probes for medical diagnostic purposes, namely, for in-vitro diagnostic of body fluids; Trace material analyzers for medical use in diagnosis, namely, for in-vitro diagnostic of body fluids; Diagnostic apparatus for medical purposes, namely, for in-vitro diagnostic of body fluids; Testing instruments for medical diagnostic purposes, namely, for in-vitro diagnostic of body fluids; Medical diagnostic apparatus for in-vitro diagnostic of body fluids; Nuclear medicine diagnostic imaging apparatus; Ultrasonic diagnostic instruments for medical use; Medical instruments, namely, Co2 irrigators for urological diagnosis; Medical instruments, namely, Co2 insufflators for endoscopic diagnosis; Medical diagnostic saliva vials; Medical apparatus for diagnosing suspected heart attacks; Ultrasonic medical diagnostic apparatus; Medical diagnostic apparatus for testing for viruses; Apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; Medical diagnostic apparatus, namely, automatic analyzers for in-vitro diagnostic of body fluids; Patient monitoring sensors and alarms; Sensor apparatus for medical use in monitoring the vital signs of patients; Medical instruments for recording physiological data; Medical instruments for reproducing physiological data

Development of medical diagnostic apparatus; Medical research and development in the field of diagnostic preparations; Design and development of medical diagnostic apparatus; Information technology services, namely, providing medical research information and in vitro diagnostic (IVD) data compiling services for research purposes for the pharmaceutical and healthcare industries; Consulting services in the field of software as a service (SaaS); Software as a service (SaaS) featuring software for deep learning; Software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks; Development of computer databases; Maintenance of computer databases; Development of data processing programs; Installation of computer database software; Preparation, update, installation and maintenance of computer data processing software programmes; Information technology consulting services, namely, technical data analysis services for computer systems in the nature of data automation and collection service using proprietary software to evaluate, analyze and collect medical data; Providing scientific research information conducted using online searchable databases in the field of healthcare; Providing scientific research information and results from an online searchable database in the field of healthcare; Medical laboratory services; Providing medical research laboratories; Medical analytical laboratory services; Scientific laboratory services; Scientific and technological services, namely, scientific laboratory testing in the field of medicine development, clinical trials and healthcare; Rental of laboratory apparatus and instruments; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information about the results of clinical trials for pharmaceutical products; Medical and scientific research, namely, conducting clinical trials for others in the field of cardiovascular disease; Providing information on clinical studies via an interactive website; Providing online nondownloadable mobile applications for displaying health information; Providing online nondownloadable computer software for health monitoring in the field of healthcare; Providing online nondownloadable artificial intelligence computer software for health status analyzation and health status monitoring in the field of healthcare; Medical laboratory services for the analysis of blood samples taken from patients; Medical laboratory services for the analysis of body fluid samples taken from patients; Consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, and individuals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 21, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 21, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 5, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 14, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 25, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 25, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 25, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 25, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 25, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2024 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 3, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 28, 2023 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Nov 14, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 10, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 29, 2023 CNRT
EXAMINER'S AMENDMENT ENTERED
Aug 21, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 21, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 21, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 21, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2023 CRFA
ASSIGNED TO LIE
May 15, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 24, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 24, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 24, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 25, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 5, 2021 NWOS
NEW APPLICATION ENTERED
Oct 22, 2021 NWAP